Explore the categories so you can find more about your search.
Categorie > Clinical Trials / Drug Trials
Treatment Of Portal Hypertensive Pulmonary Lesions Induced By Schistosomiasis
Categorie : Clinical Trials / Drug TrialsTo evaluate efficacy of Calculus Bovis compound preparation (ICCBco) in the treatment of lung lesions in portal hypertensive rabbits with schistosomiasis as the experimental animal model, a research group in China performed a randomized, double-blind, controlled trial to observe pathological changes ...
read more
Sat Mar 2010
Transcendental Meditation Activates Default Mode Network, The Brain's Natural Ground State
Categorie : Clinical Trials / Drug TrialsA new EEG study conducted on college students at American University found they could more highly activate the default mode network, a suggested natural "ground state" of the brain, during their practice of the Transcendental Meditation technique... ...
read more
Sat Mar 2010
Phase III REGION-I Study Shows PEP005 (ingenol Mebutate) Gel 0.05% May Reduce Pre-Cancerous Skin Lesions In Patients With Actinic Keratosis
Categorie : Clinical Trials / Drug TrialsSpecialty pharmaceutical company LEO Pharma announced that findings from a Phase III study evaluating PEP005 (ingenol mebutate) Gel 0.05% to treat actinic keratosis (AK), a common pre-cursor to skin cancer, were presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) (Scien ...
read more
Sat Mar 2010
ISIS Initiates Phase 1 Clinical Trial Of ISIS-SOD1Rx In Patients With ALS
Categorie : Clinical Trials / Drug TrialsIsis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS). Approximately 20 percent of all familial ALS cases are caused b ...
read more
Sat Mar 2010
COPPERTONE(R) Solar Research Center Unveils Studies On Efficacy Of Topical Antioxidants In Sunscreens At 2010 Annual Meeting
Categorie : Clinical Trials / Drug TrialsSchering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc., the makers of COPPERTONE®, announced at the 2010 Annual Meeting of the American Academy of Dermatology the results of studies demonstrating the efficacy of topical antioxidants in broad spectrum sunscr ...
read more
Sat Mar 2010
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer
Categorie : Clinical Trials / Drug TrialsPoniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castr ...
read more
Sat Mar 2010
Ocular Shingles Linked To Increased Risk Of Stroke
Categorie : Clinical Trials / Drug TrialsHaving a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers identified 658 people diagnosed with ocular s ...
read more
Fri Mar 2010
Parkinson's Disease Makes It Harder To Figure Out How Other People Feel
Categorie : Clinical Trials / Drug TrialsScientists are beginning to find out why people with Parkinson's disease often feel socially awkward. Parkinson's patients find it harder to recognize expressions of emotion in other people's faces and voices, report two studies published by the American Psychological Association... ...
read more
Fri Mar 2010
Second Dose Of Gene Therapy For Inherited Blindness Proves Safe In Animal Study
Categorie : Clinical Trials / Drug TrialsGene therapy for a severe inherited blindness, which produced dramatic improvements last year in 12 children and young adults who received the treatment in a clinical trial, has cleared another hurdle... ...
read more
Fri Mar 2010
Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival In Patients With Metastatic Castrate-Resistant Prostate Cancer
Categorie : Clinical Trials / Drug TrialsDendreon Corporation (Nasdaq: DNDN) announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate can ...
read more
Fri Mar 2010
Evidence-Based Treatment For Childhood Epilepsy
Categorie : Clinical Trials / Drug TrialsThe first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy the most common form of epilepsy in kids has established an evidence-based approach for initial drug therapy... ...
read more
Fri Mar 2010
Pneumococcal Vaccine Offers Protection To HIV-infected African Adults In Clinical Trial
Categorie : Clinical Trials / Drug TrialsA clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. The trials, conducted in Malawi and funded by the Wellcome Trust, studied the efficacy of a vaccine against infectio ...
read more
Fri Mar 2010
Evidence-Based Care For Childhood Epilepsy Follows Comparative Effectiveness Trial
Categorie : Clinical Trials / Drug TrialsThe first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy... ...
read more
Fri Mar 2010
FDA Provides 510k Clearance For BARRX Medical's HALO90 Ablation Catheter For The Treatment Of Radiation Proctitis And Gastric Antral Vascular Ectasia
Categorie : Clinical Trials / Drug TrialsBARRX Medical, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its HALO90 Ablation Catheter for the treatment of Radiation Proctitis (RP) and Gastric Antral Vascular Ectasia (GAVE). Both conditions are diseases of the gastrointestinal ...
read more
Fri Mar 2010
OmniComm Introduces TrialOneTM - An Integrated Suite Of Web Based Solutions For Phase I Clinic Automation And Management
Categorie : Clinical Trials / Drug TrialsOmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS .NET, web-based solution designed to automate the Phase I Clinical Trial Process... ...
read more
Fri Mar 2010
Pycnogenol Lowers Elevated Urinary Protein Levels And Improves Blood Flow To The Kidneys
Categorie : Clinical Trials / Drug TrialsAn estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults... ...
read more
Fri Mar 2010
Transplant Drug Preserves Kidneys, Avoids Toxicity
Categorie : Clinical Trials / Drug TrialsThe experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show. The results are published in the March issue of the Am ...
read more
Fri Mar 2010
Rexahn Pharmaceuticals Submits Zoraxel Phase IIb Protocol To FDA
Categorie : Clinical Trials / Drug TrialsRexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED). "The progressi ...
read more
Fri Mar 2010
Gynecologic Oncology Group Notifies CTI That Continuation Of GOG-212 Pivotal Trial Of OPAXIO Maintenance Therapy In Ovarian Cancer Is A Priority
Categorie : Clinical Trials / Drug TrialsCell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and ...
read more
Fri Mar 2010
ReShape Medical Announces Initiation Of U.S. Clinical Study For Weight Loss
Categorie : Clinical Trials / Drug TrialsReShape Medical™, Inc. announced that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want suppor ...
read more
Fri Mar 2010